Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
10hon MSN
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...
Related: Shannon Miller on Her Ovarian Cancer Diagnosis. The Early Ovarian Cancer Sign Most People Miss. According to experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback